(Reuters) -Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a U.S. initial public offering on Friday. The terms of the IPO were not disclosed in the filing. Strong equity markets, falling interest rates and hopes of a friendlier regulatory environment under the incoming Trump administration have…
(Reuters) – The U.S. government on Friday proposed 2026 reimbursement rates for Medicare Advantage plans run by private insurers that will result in a 2.2% increase in payments, compared with a decline of 0.2% last year. Shares of insurers UnitedHealth Group, Elevance Health, CVS Health Corp and Humana rose between 1% and 3.2% in extended…
By Tom Polansek CHICAGO (Reuters) – Workers in U.S. chicken and pork plants face higher risks than other manufacturing workers for musculoskeletal disorders such as carpal tunnel syndrome, according to two studies the U.S. Department of Agriculture issued on Friday. The findings highlight health concerns for employees who often perform repetitive tasks and use dangerous…
